Literature DB >> 16550611

Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.

Watcharin Loilome1, Puangrat Yongvanit, Chaisiri Wongkham, Nisana Tepsiri, Banchob Sripa, Paiboon Sithithaworn, Shuji Hanai, Masanao Miwa.   

Abstract

Cholangiocarcinoma (CCA) induced by liver fluke (Opisthorchis viverrini, Ov) infection is one of the most common and serious disease in northeast Thailand. To elucidate the molecular mechanism of cholangiocarcinogenesis induced by Ov infection, we employed a hamster model of CCA induced by Ov and N-nitrosodimethylamine and analyzed candidate genes involved in CCA using fluorescence differential display-PCR. Of 149 differentially amplified bands we identified, the upregulation of 23 transcripts and downregulation of 1 transcript related to CCA hamsters were confirmed by a reverse northern macroarray blot. The upregulated genes include signal transduction protein kinase A regulatory subunit Ialpha (Prkar1a), myristoylated alanine-rich protein kinase C substrate, transcriptional factor LIM-4-only domain, oxysterol-binding protein involved in lipid metabolism, splicing regulatory protein 9, ubiquitin conjugating enzyme involved in protein degradation, beta tubulin, beta actin, and collagen type VI. Quantitative real-time PCR confirmed that the expression of Prkar1a was significantly higher in CCA and its precursor lesion when compared with normal liver and normal gall bladder epithelia (P<0.05). Prkar1a expression tended to increase along with the progression of biliary transformation from hyperplasia and precancerous lesions to carcinoma. These findings contribute to our understanding of the processes involved in the molecular carcinogenesis of CCA in order to provide a unique perspective on the development of new chemotherapeutics in future. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550611     DOI: 10.1002/mc.20094

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  25 in total

1.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

2.  Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Authors:  Supak Yothaisong; Hasaya Dokduang; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Gregory J Riggins; Watcharin Loilome
Journal:  Tumour Biol       Date:  2013-07-06

Review 3.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 4.  Hilar cholangiocarcinoma: pathology and tumor biology.

Authors:  Dong Kuang; Guo-Ping Wang
Journal:  Front Med China       Date:  2010-11-25

5.  Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.

Authors:  Ian A Darby; Karine Vuillier-Devillers; Emilie Pinault; Vincent Sarrazy; Sébastien Lepreux; Charles Balabaud; Paulette Bioulac-Sage; Alexis Desmoulière
Journal:  Cancer Microenviron       Date:  2010-06-26

Review 6.  Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.

Authors:  Alphonse-E Sirica
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

7.  PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.

Authors:  Watcharin Loilome; Sasithorn Yooyuen; Nisana Namwat; Paiboon Sithithaworn; Anucha Puapairoj; Junko Kano; Masayuki Noguchi; Masanao Miwa; Puangrat Yongvanit
Journal:  Tumour Biol       Date:  2012-08-26

8.  Increased EphB2 expression predicts cholangiocarcinoma metastasis.

Authors:  Walaiporn Khansaard; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Narong Khuntikeo; Anucha Puapairoj; Watcharin Loilome
Journal:  Tumour Biol       Date:  2014-07-11

9.  Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.

Authors:  Hasaya Dokduang; Sirinun Juntana; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Narong Khuntikeo; Gregory J Riggins; Watcharin Loilome
Journal:  Tumour Biol       Date:  2013-06-29

10.  Mechanisms of oxysterol-induced disease: insights from the biliary system.

Authors:  Rahul Kuver
Journal:  Clin Lipidol       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.